(Q43411987)

English

Therapeutic efficacy of combination of antitumor agent with AHC-52 against multidrug-resistant cells in the intravenously inoculated P388 leukemia model

scientific article published on January 1, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 November 2017

Therapeutic efficacy of combination of antitumor agent with AHC-52 against multidrug-resistant cells in the intravenously inoculated P388 leukemia model (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1505070

3 October 2022

multiple drug resistance

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

H. Shinoda

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1505070

3 October 2022

H. Ebisu

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1505070

3 October 2022

J. Mitsuhashi

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1505070

3 October 2022

M. Inaba

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1505070

3 October 2022

T. Tsuruo

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1505070

3 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1505070

3 October 2022

publication date

1 January 1992

1 reference

Europe PubMed Central

23 November 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

23 November 2017

30

1 reference

Europe PubMed Central

23 November 2017

5

1 reference

Europe PubMed Central

23 November 2017

335-340

1 reference

Europe PubMed Central

23 November 2017

https://scigraph.springernature.com/pub.10.1007/bf00689959

0 references

Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells

1 reference

https://api.crossref.org/works/10.1007%2FBF00689959

21 January 2018

Mechanisms of multidrug resistance and implications for therapy

1 reference

https://api.crossref.org/works/10.1007%2FBF00689959

21 January 2018

Multidrug resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MDR1 gene expression and treatment outcome in acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidrug resistance in acute myeloid leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Detection of a multidrug resistant phenotype in acute non-lymphoblastic leukaemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of drugs that alter multidrug resistance in cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

P-glycoprotein expression and modulation of cell-membrane morphology in adriamycin-resistant P388 leukemia cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active efflux common to vincristine and daunorubicin in vincristine-resistant P388 leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The biochemistry of P-glycoprotein-mediated multidrug resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased P-glycoprotein expression and multidrug-resistant gene (mdr1) amplification are infrequently found in fresh acute leukemia cells. Sequential analysis of 15 cases at initial presentation and relapsed stage

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo circumvention of vincristine resistance in mice with P388 leukemia using a novel compound, AHC-52.

1 reference

https://pubmed.ncbi.nlm.nih.gov/1505070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00689959

1 reference

Europe PubMed Central

23 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43411987&oldid=2124963360"